TEON THERAPEUTICS
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.
TEON THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.teontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 486 1902
Email Addresses:
[email protected]
Total Funding:
37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress AJAX Libraries API Cloudflare WordPress 6.0 Cloudflare SSL Typekit
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oceanpine Capital
Oceanpine Capital investment in Series A - Teon Therapeutics
Oriental Fortune Capital
Oriental Fortune Capital investment in Series A - Teon Therapeutics
Oriza Ventures
Oriza Ventures investment in Series A - Teon Therapeutics
Kaitai Capital
Kaitai Capital investment in Series A - Teon Therapeutics
Lifespan Investments
Lifespan Investments investment in Series A - Teon Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Teon Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Seed Round - Teon Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-08 | Teon Therapeutics Names Serge Messerlian as CEO |
Official Site Inspections
http://www.teontherapeutics.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Teon Therapeutics"
Our Team | Experts in Tumor Metabolism | Teon …
As a member of BIO Board of Directors (the trade organization of biotech companies) from 1999 to 2009, Dr. Lange led the largest committee of member companies for two years and was picked as one of two biotech executives to …See details»
Oncology Drug Development | Who We Are | Teon …
Teon has assembled a powerhouse leadership team with a track record in oncology drug development and deep insights in G-protein coupled receptor (GPCR) signaling, small molecule design, along with a clear vision to push the …See details»
Teon Therapeutics - Crunchbase Company Profile & Funding
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the …See details»
Teon Therapeutics Inc. | LinkedIn
Teon Therapeutics Inc. Biotechnology Redwood City, California 1,086 followers Teon is a clinical company targeting metabolic signaling pathways and pioneering the development of GPCR therapiesSee details»
Teon Therapeutics - PitchBook
Www.teontherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 555 Twin Dolphin Drive; Suite 120; Redwood City, CA …See details»
Teon Therapeutics Names Serge Messerlian as CEO
Mar 8, 2022 For more information about Teon Therapeutics, please visit: www.teontherapeutics.com. Contacts Shani Lewis LaVoieHealthScience Email: [email protected] Phone: 609-516-5761See details»
TEON THERAPEUTICS INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TEON THERAPEUTICS INC of San Mateo, CA. Get the latest business insights from Dun & Bradstreet.See details»
Teon Therapeutics, Inc. - VentureRadar
Teon Therapeutics is a private biopharma company developing a novel pipeline of GPCR-targeting small molecules for use in oncology. GPCRs are a... ... Find out more ...See details»
Teon Therapeutics, Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... www.teontherapeutics.com. …See details»
Teon Therapeutics Names Serge Messerlian as CEO
Mar 8, 2022 Teon completed its $30M Series A financing round in February 2021. For more information about Teon Therapeutics, please visit: www.teontherapeutics.com. Media Contact: …See details»
Teon Therapeutics - Craft
Teon Therapeutics is a biopharmaceutical company that discovers and develops oral cancer medications for restoring anti-tumor immunity. Its pipeline targets unexploited metabolic …See details»
Teon Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 555 Twin Dolphin Dr Suite 120. Redwood City, California, 94065, United States. 650-486-1902See details»
Teon Therapeutics - Overview, News & Similar companies
Nov 1, 2022 www.teontherapeutics.com. Revenue <$5 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Teon Therapeutics Announces Clinical Trial Collaboration …See details»
Invest in Cancer | Teon Therapeutics | 20+ Years Experience
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of oral, GPCR-targeted small molecules …See details»
Teon Therapeutics Completes $30 Million Series A Financing - PR …
SAN FRANCISCO, Feb. 23, 2021 /PRNewswire/ -- Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer …See details»
Teon Therapeutics (@TeonTx) / Twitter
Mar 1, 2022 As a reflection of our growing company and the advancements made in our clinical stage pipeline, check out our new website showcasing Teon’s purpose of Inventing New Hope …See details»
Working at Teon Therapeutics - Glassdoor
Cons. CEO and project leaders have never worked in development. Project leaders and even some consultants refuse to answer questions, silo information, attack co-workers for asking …See details»
What's New | Teon Therapeutics
Cookie Duration Description; _ga: 2 years: The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's …See details»
Teon Therapeutics Completes $30 Million Series A Financing
SAN FRANCISCO, CA, February 22, 2021 – Teon Therapeutics, a biopharmaceutical company developing small molecules that inhibit the immunosuppressive and cancer-promoting …See details»